Colin Charnock

1.7k total citations
58 papers, 1.3k citations indexed

About

Colin Charnock is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Colin Charnock has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Infectious Diseases and 12 papers in Organic Chemistry. Recurrent topics in Colin Charnock's work include Bacterial biofilms and quorum sensing (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Water Treatment and Disinfection (5 papers). Colin Charnock is often cited by papers focused on Bacterial biofilms and quorum sensing (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Water Treatment and Disinfection (5 papers). Colin Charnock collaborates with scholars based in Norway, Puerto Rico and Sweden. Colin Charnock's co-authors include Hege Smith Tunsjø, Lise‐Lotte Gundersen, Vibeke H. Telle‐Hansen, Mari C. W. Myhrstad, Anders Benteson Nygaard, Frode Rise, Ayele H. Negussie, Roger Meisal, Rolf Larsson and Lars Bohlin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Water Research and Scientific Reports.

In The Last Decade

Colin Charnock

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Charnock Norway 21 439 373 132 125 111 58 1.3k
S. Hemalatha India 24 480 1.1× 287 0.8× 52 0.4× 86 0.7× 68 0.6× 195 2.3k
Riadh Badraoui Tunisia 27 514 1.2× 175 0.5× 246 1.9× 51 0.4× 67 0.6× 144 2.3k
Rohan Shah Australia 21 524 1.2× 152 0.4× 77 0.6× 66 0.5× 92 0.8× 61 1.5k
Barbara Bartholomew United Kingdom 23 703 1.6× 205 0.5× 45 0.3× 87 0.7× 170 1.5× 60 1.8k
Roberto Edoardo Villa Italy 22 283 0.6× 391 1.0× 54 0.4× 51 0.4× 40 0.4× 147 1.6k
G. Biagi Italy 30 812 1.8× 193 0.5× 77 0.6× 47 0.4× 144 1.3× 136 2.7k
Xiaojiao Chen China 24 787 1.8× 213 0.6× 498 3.8× 55 0.4× 112 1.0× 72 2.3k
Antonella Cavazza Italy 28 455 1.0× 128 0.3× 99 0.8× 88 0.7× 46 0.4× 90 2.3k
K. V. Bhaskara Rao India 21 426 1.0× 112 0.3× 127 1.0× 199 1.6× 40 0.4× 80 2.0k
Huaqiao Tang China 27 661 1.5× 86 0.2× 172 1.3× 51 0.4× 103 0.9× 111 1.9k

Countries citing papers authored by Colin Charnock

Since Specialization
Citations

This map shows the geographic impact of Colin Charnock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Charnock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Charnock more than expected).

Fields of papers citing papers by Colin Charnock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Charnock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Charnock. The network helps show where Colin Charnock may publish in the future.

Co-authorship network of co-authors of Colin Charnock

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Charnock. A scholar is included among the top collaborators of Colin Charnock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Charnock. Colin Charnock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amer, Ahmed M., et al.. (2025). Phospholipid acyl chain length modulation: a strategy to enhance liposomal drug delivery of the hydrophobic bacteriocin Micrococcin P1 to biofilms. European Journal of Pharmaceutical Sciences. 211. 107149–107149.
2.
Amer, Ahmed M., et al.. (2024). Genomics of Staphylococcus aureus and Enterococcus faecalis isolated from the ocular surface of dry eye disease sufferers. Experimental Eye Research. 248. 110071–110071.
3.
Amer, Ahmed M., et al.. (2024). Novel Teixobactin Analogues Show Promising In Vitro Activity on Biofilm Formation by Staphylococcus aureus and Enterococcus faecalis. Current Microbiology. 81(10). 349–349. 2 indexed citations
4.
Utheim, Tor Paaske, et al.. (2024). Whole genome sequencing and characterization of Corynebacterium isolated from the healthy and dry eye ocular surface. BMC Microbiology. 24(1). 368–368. 1 indexed citations
6.
Charnock, Colin, et al.. (2023). Exploring patients' adherence to antibiotics by understanding their health knowledge and relational communication in encounters with pharmacists and physicians. SHILAP Revista de lepidopterología. 12. 100372–100372. 5 indexed citations
7.
Klein, Jörn, et al.. (2021). Can the use of assistive technology and interactive therapeutic robots in nursing homes contribute to the spread of infectious disease?. Duo Research Archive (University of Oslo). 36(1). 25–29. 1 indexed citations
8.
Nygaard, Anders Benteson, Hege Smith Tunsjø, Roger Meisal, & Colin Charnock. (2020). A preliminary study on the potential of Nanopore MinION and Illumina MiSeq 16S rRNA gene sequencing to characterize building-dust microbiomes. Scientific Reports. 10(1). 3209–3209. 107 indexed citations
9.
Tunsjø, Hege Smith, et al.. (2019). Detection of Aminoglycoside Resistant Bacteria in Sludge Samples From Norwegian Drinking Water Treatment Plants. Frontiers in Microbiology. 10. 487–487. 18 indexed citations
10.
Charnock, Colin, et al.. (2017). Use of a Commercially Available Microarray to Characterize Antibiotic-Resistant Clinical Isolates of Klebsiella pneumoniae. Current Microbiology. 75(2). 163–172. 4 indexed citations
11.
Charnock, Colin, et al.. (2016). Proteobacteria, extremophiles and unassigned species dominate in a tape-like showerhead biofilm. Brazilian Journal of Microbiology. 47(2). 345–351. 13 indexed citations
13.
Charnock, Colin, et al.. (2011). Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles. Bioorganic & Medicinal Chemistry. 19(11). 3483–3491. 30 indexed citations
14.
Charnock, Colin, et al.. (2010). Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring. Bioorganic & Medicinal Chemistry. 18(20). 7274–7282. 22 indexed citations
15.
Charnock, Colin, et al.. (2009). Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines. Bioorganic & Medicinal Chemistry Letters. 19(12). 3297–3299. 25 indexed citations
16.
Proszenyák, Ágnes, Colin Charnock, Erik Hedner, et al.. (2007). Synthesis, Antimicrobial and Antineoplastic Activities for Agelasine and Agelasimine Analogs with a β‐Cyclocitral Derived Substituent. Archiv der Pharmazie. 340(12). 625–634. 31 indexed citations
17.
Gundersen, Lise‐Lotte, et al.. (2006). Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis. European Journal of Pharmaceutical Sciences. 30(1). 26–35. 136 indexed citations
18.
Charnock, Colin. (2004). Tatoveringsløsninger forurenset av bakterier. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
19.
Charnock, Colin. (2004). The microbial content of non-sterile pharmaceuticals distributed in Norway. Journal of Hospital Infection. 57(3). 233–240. 9 indexed citations
20.
Charnock, Colin & Tom Bergan. (1992). Multilocus enzyme electrophoresis of major O-antigen reference strains ofPseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 11(9). 810–816. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026